Fifth Third Bancorp Royalty Pharma PLC Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fifth Third Bancorp holds 533 shares of RPRX stock, worth $13,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares

533

Previous 441 20.86%

Holding current value

$13,698

Previous $11,000 36.36%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$25.63 - $29.27 $2,357 - $2,692	92 Added 20.86%	533 $15,000
Q2 2024 Jul 22, 2024	SELL	$26.26 - $29.9 $603 - $687	-23 Reduced 4.96%	441 $11,000
Q1 2024 Apr 23, 2024	SELL	$27.46 - $31.33 $149,217 - $170,247	-5,434 Reduced 92.13%	464 $14,000
Q4 2023 Jan 19, 2024	BUY	$26.21 - $29.22 $4,455 - $4,967	170 Added 2.97%	5,898 $165,000
Q3 2023 Oct 31, 2023	BUY	$26.26 - $31.38 $6,354 - $7,593	242 Added 4.41%	5,728 $155,000
Q2 2023 Jul 25, 2023	SELL	$29.6 - $36.56 $680 - $840	-23 Reduced 0.42%	5,486 $168,000
Q1 2023 Apr 24, 2023	BUY	$32.77 - $39.4 $1,704 - $2,048	52 Added 0.95%	5,509 $198,000
Q4 2022 Jan 25, 2023	SELL	$39.17 - $44.04 $470 - $528	-12 Reduced 0.22%	5,457 $0
Q3 2022 Oct 25, 2022	BUY	$39.88 - $44.65 $478 - $535	12 Added 0.22%	5,469 $219,000
Q1 2022 Apr 19, 2022	BUY	$37.46 - $42.44 $63,944 - $72,445	1,707 Added 45.52%	5,457 $213,000
Q4 2021 Feb 01, 2022	BUY	$35.17 - $42.48 $131,887 - $159,300	3,750 New	3,750 $149,000
Q3 2021 Oct 15, 2021	SELL	$36.14 - $42.24 $9,071 - $10,602	-251 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$39.85 - $46.63 $10,002 - $11,704	251 New	251 $10,000
Q1 2021 May 07, 2021	SELL	$42.34 - $52.82 $84,680 - $105,640	-2,000 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$44.5 - $52.11 $89,000 - $104,220	2,000 New	2,000 $97,000

Others Institutions Holding RPRX

# of Institutions

412

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Royalty Pharma PLC Transaction History